Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Injection of Hyperbaric Bupivacaine Versus a Mixture of Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Lower Abdominal Surgery: A Randomized Controlled Trial

NCT06050044 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT06050044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06050044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Injection of Hyperbaric Bupivacaine Versus a Mixture of Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Lower Abdominal Surgery: A Randomized Controlled Trial
Lead sponsor
Helwan University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2022
Completion date
July 1, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperbaric bupivacaine, isobaric bupivacaine, lower abdominal surgery, spinal anesthesia